CA-MARY-KAY-INC.
20.5.2021 19:05:09 CEST | Business Wire | Press release
What started out as a way for the style community to come together when the pandemic stopped the industry in its tracks has grown into one of the largest gatherings of the fashion industry worldwide. Now, with life opening back up in the US and abroad, Glamhive ’s Digital Spring Style and Beauty Summit on May 22nd will be the final 100% digital summit. Glamhive will launch all future events as a hybrid physical-digital experience.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210520005908/en/
The Spring Summit will be the company’s fifth global digital experience and will once again bring together industry professionals and beauty and style enthusiasts to discuss spring style, skincare in the colder months, getting started in the fashion business and much more.
The all-day, ticketed event will feature 19 panels with 66-plus speakers. Below is an overview of the topics that will be covered by the all-star speaker line-up.
TOPICS:
- Who Made This? How Sustainably Sourced Products Empower Women With Every Purchase
- Style 411: Inside the World of Styling
- Contemporary Costume Design: The Role, The Challenges, And It’s Influence On Fashion
- The Red Carpet Report
- “A Star Is Born” Exclusive Interview with Astrologist Susan Miller
- Exclusive Interview with Bridgerton’s Costume Designer Ellen Mirojnick
- How To Make A Great First Impression Every Time
- Brand Building for Creatives & Entrepreneurs
During the Who Made This? How Sustainably Sourced Products Empower Women With Every Purchase panel, Chief Marketing Officer for Mary Kay Inc., Sheryl Adkins-Green, will host a discussion on the origin of the items inside each of our closets—and how we can better know the innovators behind the fashion styles. Panelists include Jane Mosbacher, Founder and CEO of TO THE MARKET; Matilda Payne Boakye-Ansah, Designer, Eco-Warrior, Social Entrepreneur, Founder of MH Couture and Co-Founder of Xtreme Upcycle; Christelle C. Paul, Founder and Director of Atelier Calla; and Tara Swennen, celebrity stylist.
“We have an opportunity every day to make choices that help protect our environment,” said Sheryl Adkins-Green, “and it’s important to know about the people and products that are making a difference.”
CO-HOSTS
Stephanie Sprangers - Founder & CEO, Glamhive
Johnny Wujek - Celebrity Stylist & Costume Designer to Katy Perry and Mariah Carey
Nicole Chavez - Celebrity Stylist to Kristen Bell and Jessica Simpson
Andrew Fitzsimons - Celebrity hairstylist to The Kardashians
Claire Sulmers - Founder + CEO of Fashion Bomb Daily
SPEAKERS:
Our speakers are celebrity stylists, makeup artists, and image-makers who work with the biggest names in Hollywood and beyond, including Kristen Stewart, Angelina Jolie, Matthew McConaughey, Emily Blunt, Gabrielle Union, Zendaya, Sophie Turner, Amanda Seyfried, Margot Robbie, Lupita Nyong’o, Emma Watson, Rosie Huntington-Whiteley, Claire Danes, Carmen Electra.
CELEBRITY STYLISTS:
Jen Rade, Tara Swennen, Jessica Paster, Nicole Chavez, Sonia Young, Dana Asher Levine, Mimi Lombardo, Joiee Thorpe, Franzy Staedter.
CELEBRITY MAKEUP ARTISTS + HAIRSTYLISTS:
Sheridan Ward, Matey Denno, Matin Maulawizada, Christian Wood, Halley Brisker, Larry Sims
MODERATORS:
Brian Underwood (Oprah Magazine), Brooke Jaffe, (Penske Media), Alexis Bennett (Vogue), Sarah Ball (PEOPLE Magazine), Flavia Nunez (Real Simple), Alana Peden (StyleCaster) and Sheryl Adkins-Green (Mary Kay Inc.)
Tickets to the conference are $149 for an all-day ticket. Presenting sponsor for the Glamhive Digital Spring Style and Beauty Summit is Mary Kay Inc. and its Mary Kay Global Design Studio.
For more information, visit https://www.glamhive.com/live
About Glamhive: Glamhive was founded by entrepreneur Stephanie Sprangers in 2017 with the vision to democratize personal styling and the premise that the confidence that comes with glamour should not be exclusive to the rich and famous.
The online styling experience offers anyone with a WiFi connection access to stylists who will provide them with the support they need to be the best version of themselves. For stylists, it is a seamless end-to-end platform to help them grow their network and their business, 100% virtually.
About Mary Kay
One of the original glass ceiling breakers, Mary Kay Ash founded her beauty company nearly 60 years ago with three goals: develop rewarding opportunities for women, offer irresistible products, and make the world a better place. That dream has blossomed into a multibillion-dollar company with millions of independent sales force members in nearly 40 countries. Mary Kay is dedicated to investing in the science behind beauty and manufacturing cutting-edge skin care, color cosmetics, nutritional supplements and fragrances. Mary Kay is committed to empowering women and their families by partnering with organizations from around the world, focusing on supporting cancer research, protecting survivors from domestic abuse, beautifying our communities, and encouraging children to follow their dreams. Mary Kay Ash’s original vision continues to shine—one lipstick at a time.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210520005908/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 15:00:00 CEST | Press release
Newest expansion of the NetBrain platform delivers Agent Skills, AI Path Doctor, MCP Server, and expanded cross-domain integrations, extending the agentic capabilities already running in production at hundreds of enterprises. NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under
Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 14:00:00 CEST | Press release
News summary: Non-practicing entity litigation continues to create costly, time-consuming pressure across the technology industry Adtran has reached a full settlement following counterclaims, with payment made to Adtran and all claims dismissed with prejudice Outcome reflects Adtran’s commitment to defend its innovations, customers and business against meritless patent assertions Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consi
Meiji Seika Pharma Invests in GHIC’s Global Health Security Fund29.5.2026 13:00:00 CEST | Press release
Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, Japan; President and Representative Director: Toshiaki Nagasato) today announced that it has committed to invest in the Global Health Security Fund (GHSF), which is sponsored by Global Health Investment Corporation (GHIC), a New York-based nonprofit organization. Through this investment, Meiji Seika Pharma will support the acceleration of innovations addressing critical global health challenges, including pandemic preparedness and antimicrobial resistance (AMR). GHIC is a mission‑driven nonprofit organization that deploys private investment strategies to generate both global health impact and financial returns. GHIC recently closed its second fund in GHSF. With more than a decade of experience investing in the field of infectious disease, GHIC has contributed to addressing major global health challenges. Its portfolio companies have successfully commercialized more than a dozen products, collectively reaching over 600 million people wo
IFF Enters Into Agreement to Sell Its Food Ingredients Business to CVC29.5.2026 12:50:00 CEST | Press release
Transaction advances portfolio transformation, sharpens focus on higher-growth, higher-margin businesses, strengthens balance sheet, and enhances value creation for shareholders IFF (NYSE: IFF), a global leader in flavors, fragrances, food ingredients, and health and biosciences, today announced that it has entered into an agreement to sell its Food Ingredients business to funds advised by CVC Capital Partners, a leading global private markets manager, in a transaction that values the business at approximately $4.3 billion, representing an enterprise value-to-EBITDA multiple of approximately 10x. As part of the transaction, IFF has chosen to retain an approximately 10% minority equity interest in the business, or approximately $200 million, permitting continued collaboration and cooperation between IFF and Food Ingredients and allowing IFF and its shareholders to participate in future value creation under its new ownership. The transaction marks a significant step in IFF’s portfolio tr
BeOne Medicines Establishes Standard for Long-Term Disease Control in CLL with BRUKINSA 78-Month Data at ASCO 202629.5.2026 12:00:00 CEST | Press release
Data represents the longest reported follow-up for a next-generation BTK inhibitor in CLL, showing sustained disease control and benefit that extends beyond first-line therapyBRUKINSA plus next-generation BCL2 inhibitor sonrotoclax (ZS) delivered deep, durable, and rapid uMRD responses, raising the bar for potential time-limited treatments in CLLData reinforce BeOne’s leadership in CLL and the strength of its foundational hematology franchise BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, is advancing the treatment paradigm in chronic lymphocytic leukemia (CLL) at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting. With extensive long-term follow-up, the SEQUOIA study of BRUKINSA® (zanubrutinib) reinforces its role as the foundational BTK inhibitor, showing sustained disease control over years of therapy. These findings are further supported by real-world evidence across three large analyses encompassing more than 250,000 pati
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom